Progyny, Inc. (NASDAQ:PGNY) Receives $47.00 Average Target Price from Analysts

Progyny, Inc. (NASDAQ:PGNY – Get Free Report) has been assigned an average recommendation of “Moderate Buy” from the eight analysts that are presently covering the company, Marketbeat.com reports. One investment analyst has rated the stock with a hold recommendation and seven have assigned a buy recommendation to the company. The average 12 month price target […]

Related Keywords

United States ,Marks Livingston ,Michaele Sturmer , ,Keycorp ,Lazard Asset Management ,Canaccord Genuity Group ,Headlands Technologies ,Arcadia Investment Management Corp ,Cantor Fitzgerald ,Progyny Company Profile ,Progyny Inc ,Jpmorgan Chase Co ,Nasdaq ,Acadian Asset Management ,Get Free Report ,Genuity Group ,President Michael ,Investment Management Corp ,Asset Management ,Get Free ,Progyny Daily ,Progyny ,Nasdaq Pgny ,Epgny ,Medical ,Ratings ,Consensus ,